Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

NCT00780663 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroendocrine Tumors
Carcinoid Tumor

Interventions

DRUG: Quarfloxin

Sponsor

Cylene Pharmaceuticals